August 23, 2012
Daiichi Sankyo announced on August 22 that its anti-influenza virus drug Inavir (laninamivir) significantly reduced the incidence of influenza infection compared to placebo in a PIII study conducted in Japan. The company intends to file an application for the prophylaxis...read more